Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Sex Transm Dis. 2020 Jul;47(7):484–490. doi: 10.1097/OLQ.0000000000001189

Figure 3.

Figure 3.

Proportion of baseline site-specific infections (urogenital, rectal and pharyngeal labels) and overall cases (overall label) averted over 10 years (mean and 95% confidence intervals) as the extragenital screening probability among men being urogenitally screened was increased from 37.5% (baseline) to 60%, 80%, and 100%.